Avestar Capital, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 204 filers reported holding REPLIGEN CORP in Q3 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avestar Capital, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$774,000
-34.4%
2,921
-28.4%
0.10%
-37.1%
Q3 2021$1,180,000
+8976.9%
4,082
+2451.2%
0.15%
+1787.5%
Q2 2019$13,000
+44.4%
1600.0%0.01%
+33.3%
Q1 2019$9,000
+12.5%
1600.0%0.01%
+20.0%
Q4 2018$8,0000.0%1600.0%0.01%0.0%
Q3 2018$8,000
+14.3%
1600.0%0.01%
+25.0%
Q2 2018$7,000
+40.0%
1600.0%0.00%
+33.3%
Q1 2018$5,0000.0%1600.0%0.00%
-25.0%
Q4 2017$5,0001600.00%
Other shareholders
REPLIGEN CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 1,291,805$53,532,0002.79%
Ranger Investment Management 919,366$38,099,0002.72%
Monashee Investment Management LLC 100,000$4,144,0001.75%
Lisanti Capital Growth, LLC 49,450$2,049,0001.36%
Pier Capital, LLC 175,565$7,275,0001.26%
SANDLER CAPITAL MANAGEMENT 221,070$9,161,0000.99%
PALISADE CAPITAL MANAGEMENT, LP 630,333$26,121,0000.98%
AWM Investment Company, Inc. 120,000$4,973,0000.88%
Stephens Investment Management Group LLC 857,714$35,544,0000.86%
Summit Creek Advisors LLC 79,066$3,276,0000.68%
View complete list of REPLIGEN CORP shareholders